1025423-95-3 Usage
Uses
Used in Scientific Research:
4-[(MethylaMino)Methyl]pyrocatechol HydrobroMide is used as a selective dopamine beta-hydroxylase inhibitor for studying the role of dopamine and its metabolites in various biological processes and diseases.
Used in Biochemical Research Applications:
4-[(MethylaMino)Methyl]pyrocatechol HydrobroMide serves as a valuable tool in biochemical research, where its diverse biological activities can be harnessed to explore and understand complex biochemical pathways and mechanisms.
Used in Pharmaceutical Synthesis:
4-[(MethylaMino)Methyl]pyrocatechol HydrobroMide is utilized in the synthesis of certain pharmaceutical compounds, contributing to the development of new drugs and therapeutic agents.
Used as a Reagent in Organic Synthesis:
In the field of organic synthesis, 4-[(MethylaMino)Methyl]pyrocatechol HydrobroMide acts as a reagent, facilitating various chemical reactions and contributing to the creation of new organic compounds with potential applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1025423-95-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,5,4,2 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1025423-95:
(9*1)+(8*0)+(7*2)+(6*5)+(5*4)+(4*2)+(3*3)+(2*9)+(1*5)=113
113 % 10 = 3
So 1025423-95-3 is a valid CAS Registry Number.
1025423-95-3Relevant academic research and scientific papers
SAR studies of capsazepinoid bronchodilators. Part 1: The importance of the catechol moiety and aspects of the B-ring structure
Dalence-Guzman, Maria F.,Berglund, Magnus,Skogvall, Staffan,Sterner, Olov
, p. 2499 - 2512 (2008/09/21)
Capsazepine as well as its derivatives and analogues are general inhibitors of constriction of human small airways. From a systematic variation of the capsazepine structure, divided into four regions, SARs were established. This part concerns the catechol moiety of the A-ring as well as the 2,3,4,5-tetrahydro-1H-2-azepine moiety (the B-ring) of capsazepine. It is revealed that a conformational constrain (as a fused ring) is important and that compounds with a six-membered B-ring (as a 1,2,3,4-tetrahydroisoquinoline) in general are more potent than the corresponding isoindoline, 2,3,4,5-tetrahydro-1H-2-benzazepine and 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.
